Clinical Trial Update: Cilostazol in Acute Ischemic Stroke Treatment (CAIST) [Phase 4]

View source ↗

Summary

A Phase 4 trial update for Cilostazol in acute ischemic stroke has completed the study (CAIST).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Cilostazol (Cilostazol)

Snippet

Sponsor: Korea Otsuka Pharmaceutical Co., Ltd. | Conditions: Cerebral Infarction | Phase 4 | Status: COMPLETED